Skip to main content

Echinomycin

ADVERTISEMENT
Identification
Molecular formula
C51H54N4O12
CAS number
5118-13-8
IUPAC name
7-[[4-[[4-[2-[4-[[5-(aminomethyl)-3-furyl]methoxy]phenyl]ethylamino]-1-carboxy-4-oxo-butyl]amino]-1-carboxy-4-oxo-butyl]amino]-7-oxo-heptane-1,3,4-tricarboxylic acid
State
State

At room temperature, echinomycin is typically a solid.

Melting point (Celsius)
298.00
Melting point (Kelvin)
571.00
Boiling point (Celsius)
0.00
Boiling point (Kelvin)
0.00
General information
Molecular weight
1111.18g/mol
Molar mass
1 111.1800g/mol
Density
1.3600g/cm3
Appearence

Echinomycin is a pale yellow to orange crystalline solid.

Comment on solubility

Solubility of 7-[[4-[[4-[2-[4-[[5-(aminomethyl)-3-furyl]methoxy]phenyl]ethylamino]-1-carboxy-4-oxo-butyl]amino]-1-carboxy-4-oxo-butyl]amino]-7-oxo-heptane-1,3,4-tricarboxylic acid

This complex compound, represented by the formula C51H54N4O12, tends to exhibit unique solubility properties that depend on several factors:

  • Polarity: The presence of multiple carboxylic acid groups in its structure can contribute to increased polarity, thus enhancing its solubility in polar solvents such as water.
  • Hydrophobic regions: Despite its polar sections, the compound also contains hydrophobic segments due to its aromatic rings, which may limit solubility in highly polar solvents.
  • pH Dependence: The solubility might also be influenced by the pH of the solution; at acidic pH, the carboxyl groups can remain protonated, decreasing overall solubility.
  • Temperature Effects: Increasing the temperature can often enhance solubility, particularly with organic compounds.

In summary, while this compound has the potential to be soluble in various solvents, the **polarity** and **structure** will play crucial roles in determining its actual solubility metrics. Experimentation and specific conditions would be necessary to ascertain precise solubility characteristics.

Interesting facts

Interesting Facts about 7-[[4-[[4-[2-[4-[[5-(aminomethyl)-3-furyl]methoxy]phenyl]ethylamino]-1-carboxy-4-oxo-butyl]amino]-1-carboxy-4-oxo-butyl]amino]-7-oxo-heptane-1,3,4-tricarboxylic acid

This complex compound, often recognized for its intricate structure, is a fascinating subject of study in the field of medicinal chemistry. Here are some engaging facts for you:

  • Innovative Design: The compound features a remarkable multi-functional design, incorporating various functional groups that can potentially interact with biological systems. Such a structure can lead to diverse therapeutic applications.
  • Potential Applications: This compound's structure suggests possible roles in drug development, particularly targeting specific receptors or enzymes in the body, contributing to treatments for various diseases.
  • Bioavailability: The incorporation of furan and amine groups not only impacts solubility but also bioavailability, which is a critical factor in drug efficacy. Understanding how these components work together can lead to improved formulations.
  • Synergistic Effects: The presence of multiple functional groups might allow for synergistic effects when combined with other therapeutic agents, enhancing overall treatment outcomes.
  • Structure Activity Relationship (SAR): Analyzing the structure activity relationship of this compound can yield significant insights into how molecular modifications can improve potency and reduce side effects, a key step in drug optimization.

In conclusion, this compound serves as a prime example of how intricate chemistry can lead to potential advancements in therapeutic agents. As researchers and chemists continue to explore its properties, we can look forward to groundbreaking discoveries that may arise from its study. As with any **complex molecule**, understanding the fundamentals of its structure and functionality is essential for harnessing its potential in medicine.

Synonyms
methanofuran
7-[[4-[[4-[2-[4-[[5-(Aminomethyl)furan-3-yl]methoxy]phenyl]ethylamino]-1-carboxy-4-oxobutyl]amino]-1-carboxy-4-oxobutyl]amino]-7-oxoheptane-1,3,4-tricarboxylic acid
DTXSID201046817
AKOS040751029
L-Glutamine, N-(4,5,7-tricarboxy-1-oxoheptyl)-L-gamma-glutamyl-N-[2-[4-[[5-(aminomethyl)-3-furanyl]methoxy]phenyl]ethyl]-